Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Kevork Minas Peltekian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
Atlantic interdisciplinary research network: Social and behavioural issues in hepatitis C and HIV/AIDS
Dykeman, M. C. (PI), Gahagan, J. C. J. (CoPI), Kirkland, S. (CoPI), Mugford, G. J. G. (CoPI), Jackson, L. (CoPI), Peltekian, K. M. (CoPI), Sketris, I. S. (CoPI) & Vallis, M. M. (CoPI)
Institute of Infection and Immunity
7/1/04 → 6/30/07
Project: Research project
-
Assessment of the fibrogenic stimulation index (FSI) and the role of antifibrotic agents in the management of chronic hepatitis C
Peterson, T. C. (PI) & Peltekian, K. M. (CoPI)
Institute of Nutrition, Metabolism and Diabetes
1/1/01 → 3/31/04
Project: Research project
-
Clinical characterization of patients with primary biliary cholangitis: A report from multiple Canadian centres
Yoshida, E. M., Swain, M. G., Tsien, C., Tam, E., Bailey, R. J., Grbic, D., Ko, H. H., Ramji, A., Hilzenrat, N., Elkhashab, M., Kim, E., O’brien, M., Puglia, M. A. & Peltekian, K. M., Aug 2022, In: Canadian Liver Journal. 5, 3, p. 372-387 16 p.Research output: Contribution to journal › Article › peer-review
-
Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis
the Canadian Network for Autoimmune Liver Disease (CaNAL), 2022, (Accepted/In press) In: Hepatology.Research output: Contribution to journal › Article › peer-review
13 Citations (Scopus) -
Global multi-stakeholder endorsement of the MAFLD definition
Global multi-stakeholder consensus on the redefinition of fatty liver disease, May 2022, In: The Lancet Gastroenterology and Hepatology. 7, 5, p. 388-390 3 p.Research output: Contribution to journal › Letter › peer-review
212 Citations (Scopus) -
Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver Disease
Hanniman, E., Costa, A. F., Bowen, C. V., Abdolell, M., Stueck, A., McLeod, M., Peltekian, K., Rioux, J. & Clarke, S. E., 2022, (Accepted/In press) In: Journal of Magnetic Resonance Imaging.Research output: Contribution to journal › Article › peer-review
9 Citations (Scopus) -
Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient
Vidovic, D., Simms, G. A., Pasternak, S., Walsh, M., Peltekian, K., Stein, J., Helyer, L. K. & Giacomantonio, C. A., May 27 2021, In: Frontiers in Immunology. 12, 678028.Research output: Contribution to journal › Article › peer-review
Open Access7 Citations (Scopus)
Press/Media
-
New Findings from University Health Network Update Understanding of Cholangitis (Ethnicity, Disease Severity, and Survival In Canadian Patients With Primary Biliary Cholangitis)
10/31/23
1 item of Media coverage
Press/Media: Research